How The World's Leading Vaccine Network Reduced Protocol Deviations

Overview: 

With 9 locations in Texas, California and Louisiana, Benchmark Research is the world's leading vaccine network. Benchmark has performed over 10,000 studies on over 40,000 subjects and has received numerous awards, including being a five-time recipient of the Best Clinical Trial Site/Network award from the World Vaccine Congress.

Challenge:

Historically, Benchmark used paper charts to collect source data. In 2019, the management team concluded that they should move to electronic source but had not set a date for transition. When the pandemic hit in spring 2020, this desire became an urgency.

Solution:

Benchmark put together a team of end users to review all the competitive options. The team selected CRIO for its functionality and ease of use. The network rolled out CRIO on a couple pilot studies, then determined that all new studies would occur on the CRIO eSource system. 

"The biggest obstacle was fear. You had coordinators who had been collecting source data on paper for 20 years," explained Deborah Copeland, the network's Chief Operating Officer. "Fortunately, CRIO is very intuitive, so once the coordinators got used to it, they didn’t want to go back."